NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

CBT for Social Anxiety Disorder Delivered by School Counselors

Phase 2

Completed

Conditions: Social Anxiety Disorder

Interventions: Behavioral: Skills for Academic and Social Success
Behavioral: Skills for Life

First Posted Date: 2011-03-22

Last Posted Date: 2016-01-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 126

Registration Number: NCT01320800

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Omega-3 Fatty Acids in Tourette's Disorder

Not Applicable

Completed

Conditions: Tourette's Disorder

Interventions: Drug: Olive oil
Drug: Omega-3 Fatty Acids

First Posted Date: 2011-03-15

Last Posted Date: 2014-07-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 33

Registration Number: NCT01315327

Locations: 🇺🇸
NYU Child Study Center, New York, New York, United States

Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma

Phase 2

Terminated

Conditions: Multiple Myeloma

Interventions: Drug: Bendamustine
Drug: Bortezomib

First Posted Date: 2011-03-15

Last Posted Date: 2018-02-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 24

Registration Number: NCT01315873

Locations: 🇺🇸
New York University Langone Medical Center, New York, New York, United States

A Trial of TBL12 Sea Cucumber Extract in Patients With Untreated Asymptomatic Myeloma

Phase 2

Terminated

Conditions: Myeloma

Interventions: Drug: TBL12

First Posted Date: 2011-02-24

Last Posted Date: 2015-02-12

Lead Sponsor: NYU Langone Health

Target Recruit Count: 20

Registration Number: NCT01302366

Locations: 🇺🇸
New York University School of Medicine, Clinical Cancer Center, New York, New York, United States

Intervening With and Improving Care for Patients at Risk for Frequent Hospital Admissions

Phase 1

Completed

Conditions: Hospitalization
Patient Readmission

First Posted Date: 2011-02-09

Last Posted Date: 2016-03-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 19

Registration Number: NCT01292096

Locations: 🇺🇸
Bellevue Hospital Center Department of Emergency Medicine, A345, New York, New York, United States

Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: Carboplatin
Radiation: 3D-RT or IMRT

First Posted Date: 2011-02-03

Last Posted Date: 2021-01-12

Lead Sponsor: NYU Langone Health

Target Recruit Count: 92

Registration Number: NCT01289353

Locations: 🇺🇸
NYU Cancer Center, New York, New York, United States

Image Guided Therapy in the Treatment of Gliomas

Not Applicable

Terminated

Conditions: Glioma

Interventions: Procedure: Diffusion-weighted magnetic resonance imaging
Procedure: Perfusion-weighted magnetic resonance imaging
Procedure: Functional magnetic resonance imaging
Procedure: Magnetic resonance spectroscopic imaging
Procedure: Therapeutic conventional surgery
Procedure: Quality-of-life assessment
Procedure: Radiation therapy treatment planning/simulation
Procedure: Intensity-modulated radiation therapy
Other: Questionnaire administration

First Posted Date: 2010-12-21

Last Posted Date: 2017-08-04

Lead Sponsor: NYU Langone Health

Target Recruit Count: 15

Registration Number: NCT01263821

Locations: 🇺🇸
NYU Cancer Institute, New York, New York, United States

Women With Epilepsy: Pregnancy Outcomes and Deliveries

Completed

Conditions: Epilepsy

First Posted Date: 2010-12-14

Last Posted Date: 2016-03-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 199

Registration Number: NCT01259310

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
North Shore Long Island Jewish Health System, Great Neck, New York, United States
🇺🇸
NYU Langone Medical Center, New York, New York, United States